Plain-English translation of NCT00398177 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Stanford University are studying lymphoma cells to better understand how the disease grows and spreads. By collecting and examining tissue samples from people with lymphoma, they hope to develop new materials and tools that could eventually be used to treat lymphoma or help doctors monitor how well treatment is working.
Currently, doctors need better ways to understand and track lymphoma. This research aims to fill that gap by studying actual lymphoma tissue, which could lead to more effective treatments and improved ways to monitor patient response to existing therapies.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will donate a lymph node tissue sample that is being removed during a routine procedure you're already scheduled for (such as a tonsillectomy). The researchers will then study these cells in the laboratory to understand more about how lymphoma develops. There are no additional visits or treatments required beyond your standard medical care.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States
The Leukemia and Lymphoma Society, Biospect Inc
Enrollment target
~9,999 participants
Started
January 1999
Primary completion
January 2099
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Alyssa M Kanegai
Stanford University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.